|
|
楼主 |
发表于 2025-2-21 00:22:58
|
显示全部楼层
马骏院士团队被接收一篇JAMA、一篇Cancer Cell，另有8项临床试验在进行中. ^5 Z' s. y( F' N& n
Whole-course Concurrent and Adjuvant Nivolumab Combined with Induction Chemotherapy Followed by Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03984357, Cancer Cell, 2025,已接收)# w" ?0 E; T. s
. q5 H2 M9 D; ?) O }" R1 ^
Adjuvant PD-1 Antibody in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Multi-center, Randomised Controlled, Phase 3 Trial (NCT03427827, JAMA, 2025,已接收)1 Q6 I5 m2 |& q8 o4 k7 Z
0 ~$ r8 p6 A& C4 A* `
GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma (NCT06455410, 进行中)2 b7 D! `; w' { n$ s( a
Individualized Elective Neck Irradiation in NPC Patients (NCT06241612, 进行中)
9 _9 w! I' @* Q; |6 O* R& \Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response (NCT06239727, 进行中)# z5 ~7 T$ b4 Y* ~$ O
Cadonilimab (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma (NCT05587374, 进行中)4 j' A* j4 i' n( g& ?; I7 ?
TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05563480, completed)
& h( E6 s, }4 f4 p9 ]+ fCombining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients (NPC-LN) (NCT05389306, 进行中)- Z6 c/ ^" _4 P* h* i, H
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma (NCT05342792, 进行中). E) c* K! E$ m1 L# N5 O
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN) (NCT05044117, 进行中) |
|
发表于 2025-2-21 07:34:13
